ES478485A1 - Procedimiento para la preparacion de 1-oxo-1h-pirimido (6-1-b) benzotiazoles. - Google Patents

Procedimiento para la preparacion de 1-oxo-1h-pirimido (6-1-b) benzotiazoles.

Info

Publication number
ES478485A1
ES478485A1 ES478485A ES478485A ES478485A1 ES 478485 A1 ES478485 A1 ES 478485A1 ES 478485 A ES478485 A ES 478485A ES 478485 A ES478485 A ES 478485A ES 478485 A1 ES478485 A1 ES 478485A1
Authority
ES
Spain
Prior art keywords
pyrimido
oxo
processes
preparation
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES478485A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of ES478485A1 publication Critical patent/ES478485A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/557—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Procedimiento para la preparación de loxo-lh- pirimido [6,1-b] benzotiazoles de la fórmula general I **(formula)** en que R1, R2, R3 y R4 significan en cada caso hidrógeno o halógeno, un grupo hidroxi, nitro o trifluorometilo, un radical alcohilo, alcoxi o alcohiltio inferior de cadena recta o ramificado, pudiendo representar R2 y R3 también conjuntamente un grupo alcohilendioxi, y X significa un grupo hidroxi, alcoxi o tetrazolili- 5-amino, y de sus sales farmacológicamente compatibles.
ES478485A 1978-03-13 1979-03-09 Procedimiento para la preparacion de 1-oxo-1h-pirimido (6-1-b) benzotiazoles. Expired ES478485A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782810863 DE2810863A1 (de) 1978-03-13 1978-03-13 1-oxo-1h-pyrimido eckige klammer auf 6,1-b eckige klammer zu benzthiazol-derivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
ES478485A1 true ES478485A1 (es) 1979-11-01

Family

ID=6034315

Family Applications (1)

Application Number Title Priority Date Filing Date
ES478485A Expired ES478485A1 (es) 1978-03-13 1979-03-09 Procedimiento para la preparacion de 1-oxo-1h-pirimido (6-1-b) benzotiazoles.

Country Status (13)

Country Link
US (1) US4232024A (es)
EP (1) EP0005154B1 (es)
JP (1) JPS54122282A (es)
AT (1) AT372965B (es)
AU (1) AU4486379A (es)
CA (1) CA1103666A (es)
DD (1) DD142343A5 (es)
DE (2) DE2810863A1 (es)
DK (1) DK96579A (es)
ES (1) ES478485A1 (es)
FI (1) FI790831A (es)
IL (1) IL56808A0 (es)
ZA (1) ZA791053B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474792A (en) * 1979-06-18 1984-10-02 Riker Laboratories, Inc. N-Tetrazolyl benzamides and anti-allergic use thereof
US4432986A (en) * 1979-06-18 1984-02-21 Riker Laboratories, Inc. Tetrazoles bonded to certain polycyclic aromatic systems and anti-allergic use thereof
US4535081A (en) * 1979-11-23 1985-08-13 Pfizer Inc. Antiallergic and antiulcer 1-oxo-1H-thiazolo[3,2-a]pyrimidine-2-carboxamides and intermediates therefor
DK151811C (da) * 1979-11-23 1988-06-06 Pfizer Analogifremgangsmaade til fremstilling af n-(5-tetrazolyl)-1-oxo-1h-thiazolooe3,2-aaa-pyrimidin-2-carboxamider eller farmaceutisk acceptable kationsalte deraf samt 1-oxo-1h-thiazolooe3,2-aaapyrimidin-2-carboxylsyrer til anvendelse som udgangsmaterialer ved fremgangsmaaden
US4377579A (en) * 1981-12-03 1983-03-22 Minnesota Mining And Manufacturing Company N-(Tetrazol-5-yl)phenazine-1-carboxamides
US4507477A (en) * 1982-09-09 1985-03-26 Riker Laboratories, Inc. Process for tetrazolyl-pyrimidinone derivatives
US4762840A (en) * 1984-02-13 1988-08-09 Roussel Uclaf Pyrimido[2,1-b]benzothiazoles having antiallergic activity
GB8519261D0 (en) * 1985-07-31 1985-09-04 Roussel Lab Ltd Chemical compounds
GB8403739D0 (en) * 1984-02-13 1984-03-14 Roussel Lab Ltd Chemical compounds
JPS6357522A (ja) * 1986-08-28 1988-03-12 Mect Corp ピリミド〔２，１−ｄ〕ベンゾチアゾ−ル誘導体からなる血小板凝集抑制剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH491944A (de) * 1966-11-29 1970-06-15 Ciba Geigy Verfahren zur Herstellung von benzheterocyclischen Verbindungen
DE2126148A1 (en) 1971-05-26 1972-12-07 Farbenfabriken Bayer Ag, 5090 Leverkusen Prepn of uracil derivs - useful as plant - protection agents and their inters
US4041163A (en) * 1976-03-29 1977-08-09 Pfizer Inc. N-(5-Tetrazolyl)-4-oxo-4H-pyrimido(2,1-b)benzothiazole-3-carboxamide antiallergy agents

Also Published As

Publication number Publication date
EP0005154B1 (de) 1981-11-25
AU4486379A (en) 1979-09-20
DE2810863A1 (de) 1979-09-27
AT372965B (de) 1983-12-12
IL56808A0 (en) 1979-05-31
CA1103666A (en) 1981-06-23
DK96579A (da) 1979-09-14
EP0005154A1 (de) 1979-11-14
DE2961394D1 (en) 1982-01-28
DD142343A5 (de) 1980-06-18
FI790831A (fi) 1979-09-14
US4232024A (en) 1980-11-04
ATA183279A (de) 1983-04-15
JPS54122282A (en) 1979-09-21
ZA791053B (en) 1980-04-30

Similar Documents

Publication Publication Date Title
ES480542A1 (es) Metodo para producir derivados de imidazol.
ES8308843A1 (es) Un procedimiento para la preparacion de compuestos.
ES8202546A1 (es) Metodo de producir derivados de tiazolidina
JPS5630964A (en) Novel substituted quinolinecarboxylic acid and its preparation
ES482918A1 (es) Procedimiento para la preparacion de derivados de indanilo
ES478485A1 (es) Procedimiento para la preparacion de 1-oxo-1h-pirimido (6-1-b) benzotiazoles.
ES8506652A1 (es) Un metodo de preparar dihidrobenzopirrolbenzodiazepinas
ES8401942A1 (es) Procedimiento para la preparacion de n-piridil-amidas de acido 1-fenil-ciclopentancarboxilico.
IE40335B1 (en) Pyrazole derivatives, process for their preparation and their use as medicaments
ES482675A1 (es) Un procedimiento para la preparacion de nuevos derivados de oxadiazolopirimidina.
ES8400103A1 (es) "un procedimiento para la preparacion de nuevos acilderivados de cefalosporina".
ES8401926A1 (es) Un procedimiento para la preparacion de un compuesto de hidroxibencilaminobenceno, dotado de propiedades antiinflamatorias.
ES8105330A1 (es) Un procedimiento para la preparacion de derivados de tiazolo(2,3-b)benzo(y azobenzo)tiazol
ES8301219A1 (es) Procedimiento para la preparacion de 2-fenilamino-imidazoli-nas-(2) sustituidas
DE3060143D1 (en) N-azolyl acetic acid anilides, process for their preparation and their use as herbicides
ES8301480A1 (es) Un procedimiento para la produccion de derivados de 11-piperazinil-5h--pirrolo 1,2-b, 1,2,5 benzotriazepina.
ES8506688A1 (es) Un procedimiento para preparar espiro (benzofuran-2(3h), 1'-cicloalcanos) sustituidos en posicion 2'
PT80955B (en) Process for preparing substituted pyridazinones and pharmaceutical preparations containing these compounds and the use thereof
ES8206534A1 (es) Un procedimiento para la preparacion de derivados acilicos de cefalosporina
SE8703494D0 (sv) Mellanprodukter anvendbara vid framstellning av 2-tiofen-ettiksyraderivat
ES485182A1 (es) Procedimiento para la preparacion de nuevos imidazo (1,2-a) imidazoles
ES8401062A1 (es) Procedimiento para la preparacion de nuevas 1-furil-3,4-dihidroisoquinoleinas.
ES466026A1 (es) Procedimiento para la obtencion de ditiocarbamatos de hidro-xialquilo.
ES485801A1 (es) Un procedimiento de preparacion de ciclo-1,3,2-oxazafosfo- ril-derivados
JPS5547651A (en) Production of sulfoxyimine